In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...